Emmerich Ilka Ute
Institut für Pharmakologie, Pharmazie und Toxikologie, Veterinärmedizinische Fakultät der Universität Leipzig.
Tierarztl Prax Ausg K Kleintiere Heimtiere. 2023 Apr;51(2):116-122. doi: 10.1055/a-2063-3247. Epub 2023 May 25.
In 2022, 3 novel pharmaceutical A: gents for small animals were released on the German market: the peripheral selective α-adrenoceptor antagonist vatinoxan in combination with medetomidine (Zenalpha), mesenchymal stem cells from the umbilical cord of horses (DogStem) and the ectoparasitic agent tigolaner in combination with emodepside and praziquantel (Felpreva). No active substance received an animal species extension. In addition, for small animals, there were new releases of four active ingredients in a novel pharmaceutical formulation (acetylcysteine, clindamycin, metoclopramide, oclacitinib maleate), one drug with a new content of the active ingredient (firocoxib) and one veterinary drug with a new combination of active ingredients in a novel pharmaceutical formulation (ketoconazole+marbofloxacin+prednisolone).
2022年，三种新型兽用药品A在德国市场上市：用于小动物的外周选择性α-肾上腺素能受体拮抗剂瓦替诺昔康与美托咪定联合制剂（Zenalpha）、马脐带间充质干细胞（DogStem）以及外寄生虫药替戈拉纳与埃莫普西和吡喹酮联合制剂（Felpreva）。没有活性物质获得动物种属扩展。此外，对于小动物，有四种活性成分以新型药物制剂形式上市（乙酰半胱氨酸、克林霉素、甲氧氯普胺、马来酸奥克拉替尼），一种药物的活性成分含量有新变化（非罗考昔），还有一种兽药以新型药物制剂形式含有活性成分新组合（酮康唑+马波沙星+泼尼松龙）。
